Luan Chunyan, Li Yongzhu, Liu Zhigang, Zhao Cunxin
Department of Gastroenterology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, People's Republic of China.
Department of Cardiology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, People's Republic of China.
Onco Targets Ther. 2020 Apr 30;13:3653-3665. doi: 10.2147/OTT.S242300. eCollection 2020.
Colon cancer (CC) is a leading cause of cancer-related deaths worldwide. This study aimed to clarify the effect of long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) on CC progression and the potential mechanism.
CC cell lines HCT116 and HT29 were selected for functional analysis. The expression of MALAT1, , and stanniocalcin 1 (STC1) in CC tissues and cells were measured by quantitative reverse transcription PCR (qRT-PCR). Cell proliferation, apoptosis, migration and invasion were measured by Cell Counting Kit-8 (CCK-8), flow cytometry, wound scratch and transwell assay, respectively. The target relationships (MALAT1 and and STC1) were validated by dual-luciferase reporter and RNA pull-down assay.
The expression of MALAT1 was elevated in CC tissues compared with adjacent normal tissues and was associated with lymph node metastasis, depth of invasion and tumor-node-metastasis (TNM) stage. Up-regulation of MALAT1 promoted the proliferation, migration, and invasion and inhibited the apoptosis of CC cells; while MALAT1 knockdown exhibited opposite results. M was a target of MALAT1, which was negatively regulated by MALAT1. Silencing of miR-101-3p reverses the anti-tumor effect of MALAT1 knockdown on CC cells. STC1 was a target of , which was negatively regulated by . Silencing of STC1 reverses the tumor promoting effects of MALAT1 up-regulation and miR-101-3p down-regulation on CC cells.
MALAT1 may function as an oncogene in CC progression by affecting the /STC1 axis, providing a hopeful therapeutic option for CC.
结肠癌(CC)是全球癌症相关死亡的主要原因。本研究旨在阐明长链非编码RNA(lncRNA)转移相关肺腺癌转录本1(MALAT1)对CC进展的影响及潜在机制。
选择CC细胞系HCT116和HT29进行功能分析。采用定量逆转录PCR(qRT-PCR)检测CC组织和细胞中MALAT1、miR-101-3p和骨钙素1(STC1)的表达。分别通过细胞计数试剂盒-8(CCK-8)、流式细胞术、划痕实验和Transwell实验检测细胞增殖、凋亡、迁移和侵袭。通过双荧光素酶报告基因和RNA下拉实验验证靶标关系(MALAT1与miR-101-3p和STC1)。
与相邻正常组织相比,CC组织中MALAT1的表达升高,且与淋巴结转移、浸润深度和肿瘤-淋巴结-转移(TNM)分期相关。MALAT1的上调促进了CC细胞的增殖、迁移和侵袭,并抑制了其凋亡;而MALAT1基因敲低则表现出相反的结果。miR-101-3p是MALAT1的靶标,受MALAT1负调控。miR-101-3p沉默可逆转MALAT1基因敲低对CC细胞的抗肿瘤作用。STC1是miR-101-3p的靶标,受miR-101-3p负调控。STC1沉默可逆转MALAT1上调和miR-101-3p下调对CC细胞的促肿瘤作用。
MALAT1可能通过影响miR-101-3p/STC1轴在CC进展中发挥癌基因作用,为CC提供了一种有希望的治疗选择。